Creating engineered cell lines represents a powerful resource for analyzing gene role and pathology pathways. This overview outlines the core principles behind generating engineered cell lines, addressing techniques like CRISPR-Cas9, RNA interference (RNAi), and homologous recombination. Moreover, we examine key considerations, including off-target